Archive for September 21st, 2010

Vivus Weight Loss Drug Effective Over Two Year Period

Vivus Inc. (NASDAQ: VVUS) is up 9.55% to $6.77 in pre-market trading following an announcement that the company’s experimental weight loss drug, Qnexa, helped overweight people lose an average of 11.4% of their body weight after two years in a clinical trial for the drug.  Vivus has already traded 460,503 shares, which is a significant [...]